National Cardiovascular Data Registry (NCDR)-based logistic regression model is available for clinicians to predict in-hospital all-cause mortality after a percutaneous coronary intervention (PCI). However, this model has never been used to predict long-term all-cause mortality after PCI. Therefore, we sought to test the ability of the NCDR model to predict the short- and long-term risk of all-cause mortality in patients undergoing PCI. All patients undergoing PCI in the Mayo Clinic Health System were enrolled in the Mayo Clinic CathPCI registry. Patient-level demographic, clinical, and angiographic data from January 2006 to December 2017 were extracted from the registry. Patients who underwent coronary artery bypass graft surgery (CABG) were excluded. The area under the receiver operator characteristic curve (AUC) was calculated to assess the ability of the NCDR model to predict outcomes of interest (6-month, 1-year, 2-year, and 5-year all-cause mortality) after PCI. A total of 17,356 unique patients were included for the final analysis after excluding 165 patients who underwent CABG surgery. The mean age was 66.9 ± 12.5 years, and 71% were men. The 6-month, 1-year, 2-year, and 5-year all-cause mortality rates were 4.2% (n = 737), 5.8% (n = 1,005), 8.06% (n = 1,399), and 14.2% (n = 2,472), respectively. The AUCs of the NCDR model to predict 6-month, 1-year, 2-year, and 5-year all-cause mortality were 0.84 (95% CI: 0.82–0.86), 0.82 (95% CI: 0.80–0.84), 0.80 (95% CI: 0.79–0.81), and 0.78 (95% CI: 0.77–0.79), respectively. The NCDR model was able to accurately predict both short- and long-term all-cause mortality after PCI.

1.
Kassaian
SE
,
Saroukhani
S
,
Alaeddini
F
,
Salarifar
M
,
Capodanno
D
,
Poorhoseini
H
, et al.
A risk-scoring model to predict one-year major adverse cardiac events after percutaneous coronary intervention
.
J Tehran Heart Cent
.
2015
;
10
(
4
):
167
75
.
2.
Brener
SJ
,
Tarantini
G
,
Leon
MB
,
Serruys
PW
,
Smits
PC
,
von Birgelen
C
, et al.
Cardiovascular and noncardiovascular death after percutaneous coronary intervention: insights from 32 882 patients enrolled in 21 randomized trials
.
Circ Cardiovasc Interv
.
2018
;
11
:
e006488
.
3.
Spoon
DB
,
Psaltis
PJ
,
Singh
M
,
Holmes
DR
,
Gersh
BJ
,
Rihal
CS
, et al.
Trends in cause of death after percutaneous coronary intervention
.
Circulation
.
2014
;
129
(
12
):
1286
94
. .
4.
Parasca
CA
,
Head
SJ
,
Milojevic
M
,
Mack
MJ
,
Serruys
PW
,
Morice
MC
, et al.
Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: the SYNTAX trial at 5 years
.
JACC Cardiovasc Interv
.
2016
;
9
(
24
):
2493
507
. .
5.
Peterson
ED
,
Dai
D
,
DeLong
ER
,
Brennan
JM
,
Singh
M
,
Rao
SV
, et al.
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry
.
J Am Coll Cardiol
.
2010
;
55
(
18
):
1923
32
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.